Partial characterization of a cell-free hemolytic factor produced by Helicobacter pylori

Metabolism and genetics of Helicobacter pylori: the genome era

The publication of the complete sequence of Helicobacter pylori 26695 in 1997 and more recently that of strain J99 has provided new insight into the biology of this organism. In this review, we attempt to analyze and interpret the information provided by sequence annotations and to compare these data with those provided by experimental analyses. After a brief description of the general features of the genomes of the two sequenced strains, the principal metabolic pathways are analyzed. In particular, the enzymes encoded by H. pylori involved in fermentative and oxidative metabolism, lipopolysaccharide biosynthesis, nucleotide biosynthesis, aerobic and anaerobic respiration, and iron and nitrogen assimilation are described, and the areas of controversy between the experimental data and those provided by the sequence annotation are discussed. The role of urease, particularly in pH homeostasis, and other specialized mechanisms developed by the bacterium to maintain its internal pH are also considered. The replicational, transcriptional, and translational apparatuses are reviewed, as is the regulatory network. The numerous findings on the metabolism of the bacteria and the paucity of gene expression regulation systems are indicative of the high level of adaptation to the human gastric environment. Arguments in favor of the diversity of H. pylori and molecular data reflecting possible mechanisms involved in this diversity are presented. Finally, we compare the numerous experimental data on the colonization factors and those provided from the genome sequence annotation, in particular for genes involved in motility and adherence of the bacterium to the gastric tissue.

Haemolytic activity of Helicobacter pylori against human and animal erythrocytes

Clinical isolates and reference strains of H. pylori (n = 28) were investigated for lytic activity against red blood cells (RBC) of man, sheep, horse, rabbit, hamster and guinea pig. The test medium (HTA) consisted of agar base supplemented with newborn calf serum and washed RBC. In contrast to previous reports, haemolysis of human RBC was detected. Blood group A RBC supported the haemolytic growth of all strains studied. On HTA with blood group 0 RBC, one strain failed to grow and five strains grew nonhaemolytically. The diversity of growth and haemolysis on HTA containing the human and several animal RBC species allowed a differentiation of the strains into eight groups. Using a liquid RBC assay for quantitative measurement of haemolysis, extracts of broth-grown cells of strain ATCC 43504 showed an average haemolysis rate of 75% against sheep RBC and of 83% against human A RBC. Cell-free culture supernatants, however, showed an average haemolysis rate of 57% against sheep RBC and no activity against human A RBC. The data indicate that H. pylori expresses an intracellular haemolytic factor and a cell surface-associated or secreted haemolytic factor which have different RBC specificities. The demonstration of the sensitivity of human RBC supports the hypothesis that the haemolytic property of H. pylori is involved in the pathogenesis of human infection.

Helicobacter pylori factors associated with disease development

Although certain factors appear to predispose the host to infection by Helicobacter pylori, clearly the bacterium possesses a well-defined battery of virulence factors that allow the organism to: (1) colonize the gastric mucosa (urease, flagella, adhesins, acid-inhibitory protein, iron acquisition proteins, and heat shock proteins); (2) evade host defense (shedding of surface proteins, catalase, superoxide dismutase, and poorly reactive lipopolysaccharide); and (3) damage host tissue (vacuolating cytotoxin, protease, CagA-related factors, inducers of cytokines, and chemotaxins). Together these factors allow H. pylori to persist in the host, establishing a chronic infection. Although many of these virulence factors are produced by all strains of H. pylori, there are also well-defined pathogenicity islands (contiguous stretches of chromosomal DNA) present in some strains that encode additional proteins including CagA that potentiate virulence. Strains possessing these "virulence cassettes" are isolated more frequently from patients with the more serious clinical manifestations associated with duodenal ulcer than from patients with gastritis alone or nonulcer dyspepsia.

Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence

Helicobacter pylori, the etiologic agent of gastritis and peptic ulceration, may infect the gastric mucosa of over half of the world's population. Despite the high infection rate, symptomatic disease beyond gastritis (characterized by gastric or duodenal ulcer) is noted in a small, but nevertheless significant, fraction of this population. What defines an H. pylori strain as a pathogen that can cause the more serious clinical manifestations? In addition to the more well recognized virulence determinants, such as urease, flagella, and vacuolating cytotoxin, evidence is emerging that the more virulent strains possess well defined segments of DNA. These "pathogenicity islands" include cytotoxin-associated gene A and encode proteins involved in signal transduction events that may facilitate intimate attachment to host cells, cytoskeletal rearrangement via actin polymerization, and host cell protein phosphorylation.

Partial characterization of Streptococcus suis type 2 hemolysin

Streptococcus suis type 2 was evaluated for hemolysin production. Supernatants of S. suis type 2 grown in Todd-Hewitt broth were assayed for hemolytic activity by a photometric assay. Twenty-two additional serotypes of S. suis (1,3 to 22, and 1/2) were evaluated for hemolysin production; nine of them (1/2, 1, 4, 5, 14, 15, 17, 19, and 20) were positive. The effects of temperature, atmosphere, centrifugation, sonication, chemicals, bovine serum albumin, fetal calf serum, and enzymes on S. suis type 2 hemolysin activity were studied. Maximum hemolysis occurred after incubation in RPMI 1640 medium at 40 degrees C in 6% CO2 and after growth in Todd-Hewitt broth at 37 degrees C under anaerobic conditions. Hemolytic activity was absent after the addition of fetal calf serum and decreased after the addition of trypsin or amylase. However, treatment of erythrocytes with amylase or trypsin prior to incubation with supernatant also resulted in a decrease in hemolytic activity. The addition of bovine serum albumin caused increased hemolytic activity. Dipyridyl and EDTA had negligible effects on hemolysis. Hemolytic S. suis type 2 culture supernatant injected intraperitoneally failed to cause death in BALB/c mice. Data from our study indicate that S. suis type 2 hemolysin is a secreted or loosely cell bound, thermolabile molecule whose activity is growth condition dependent.